Two invalidation decisions involving the US pharmaceutical company provide guidance on the building of a patent portfolio in China and the filing of supplementary experimental evidence, says Yue Guan of Wanhuida Intellectual Property
Beyond the language barrier, there are special considerations in formulating an intellectual property portfolio in Taiwan and China, write Wisdom Law s George J.H. Huang and Foley & Lardner s Kiri Lee Sharon
This week in Other Barks & Bites: Nokia files patent infringement lawsuit against Amazon and HP in multiple jurisdictions; the CAFC issues a precedential decision upholding an attorneys' fe award for Amazon, and the Biden Administration announces the establishment of the new AI Safety Institute
Company to Host Conference Call Today, November 1, at 4:30pm ETBOCA RATON, Fla., Nov. 01, 2023 (GLOBE NEWSWIRE) INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today announces its financial results for the quarter ended September 30, 2023 and provides a business update. Q3 2023 Corporate Highlights: DN-TNF Platform Highlights (XPro™): AD02 blinded randomized p